A webpage about psilocybin as a treatment for repetitive mild head injury failed to load due to technical issues with browser extensions, network connectivity, or settings.
A public health scientist investigates Amanita muscaria gummies sold in smoke shops as 'magic mushrooms,' discovering they contain muscimol, a compound that works differently from psilocybin by acting on GABA-A receptors to inhibit rather than stimulate brain activity, raising safety and legal questions.